Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow GlucoTrack, Inc.

Get SEC filing alerts via email and in your feed for GlucoTrack, Inc.

GCTK

GlucoTrack, Inc.

About GlucoTrack, Inc.

Glucotrack, Inc. develops innovative medical devices focused on non-invasive and implantable continuous blood glucose monitoring systems for people with Type 1 and insulin-dependent Type 2 diabetes. Its core product, the Glucotrack CBGM, aims to provide long-term, accurate, and convenient glucose measurement without fingersticks. The company targets the growing diabetes market, leveraging advanced sensor technology, regulatory expertise, and strategic manufacturing partnerships to improve patient outcomes and address unmet needs in glucose management.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from GlucoTrack, Inc.

1
1
GlucoTrack, Inc. GlucoTrack Reports $4.3 Million Net Loss in Q1 2026, Focuses on Product Development

Via official filing (AI summary) | 20 days ago | 0 comments

2
1
GlucoTrack, Inc. GlucoTrack Reports $19.4 Million Net Loss, Focuses on Glucotrack CBGM Development

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
GlucoTrack, Inc. GlucoTrack Reports Q3 2025 Financial Results with $4.2 Million Net Loss

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
GlucoTrack, Inc. GlucoTrack Reports Increased Net Loss and Advances Product Development in Latest 10-Q Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
GlucoTrack, Inc. GlucoTrack Reports $6.8 Million Net Loss and Increased Cash Position for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
GlucoTrack, Inc. GlucoTrack Reports $22.6 Million Net Loss and Faces Financial Challenges in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
GlucoTrack, Inc. GlucoTrack Reports Significant Financial Challenges, Net Losses, and Doubt About Future Operations

Via official filing (AI summary) | over 1 year ago | 0 comments